The outcome of patients presenting to the emergency department with severe sepsis or septic shock
Critical Care volume 10, Article number: 154 (2006)
Although multiple studies of acute myocardial infarction, trauma, and stroke have been translated into improved outcomes by applying diagnosis and therapy at the most proximal stage of hospital presentation (before intensive care unit arrival), this approach to the sepsis patient has been lacking. In response to this, a trial comparing early goal-directed therapy (EGDT) versus standard care was performed using internally and externally validated criteria for early identification of high risk patients, established definitions, and a consensus-derived protocol to reverse the hemodynamic perturbations of hypovolemia, vasoregulation, myocardial suppression and increased metabolic demands. That trial of EGDT resulted in significant reductions in morbidity, mortality, vasopressor use, and health care resource consumption. The end-points used in the protocol and the outcome results were subsequently externally validated, revealing similar or better mortality benefit. This commentary examines the rational and validation for the use of early markers of illness severity. Current evidence support the endpoints in the EGDT protocol, external validity in regards to outcome benefit and the universal need to improve the quality of care for early sepsis.
A recent retrospective, observational study by Ho and coworkers  measured the incidence and outcome of septic patients presenting at an Australian emergency department (ED) with criteria for early goal-directed therapy (EGDT) and found significantly fewer EGDT candidates than previous studies . A number of initiatives aiming to reduce worldwide mortality associated with sepsis, such as the Surviving Sepsis Campaign, have previously noted the importance of the tenets of early hemodynamic optimization to try and overcome this devastating disease. In patients with severe sepsis or septic shock, clinicians must be aware that a considerable proportion of those with significant lactic acidosis can have near normal serum bicarbonate or normal calculated anion gap values, which may lead to underestimated disease severity [3–5]. In the EGDT study , of the patients enrolled with a lactate level greater than 4 mmol/l, more than 30% had a bicarbonate level greater than 22 and an anion gap of less than or equal to 15 mEq/l. Other studies have shown that even if an anion gap is present, the mortality rate is significantly higher for lactic acidosis (56%) than for strong ion gap acidosis (39%) and hyperchloremic acidosis (29%) . Despite mentioning lactate as a criterion in the study, Ho and coworkers did not report data regarding the levels or number of measurements found. Thus, it is possible that they underestimated the prevalence of high-risk patients in need of early hemodynamic optimization. This may explain why they strikingly found only 50 patients over 3.5 years (14.2 per year) meeting criteria for severe sepsis and septic shock in a large teaching hospital emergency department (ED) that sees 40,000 patients each year with a 30% admission rate.
The lactate level of 4 mmol/l, as used in the EGDT study, was internally and externally validated. In their study of 1218 patients, Aduen and colleagues  found that lactate concentrations above 4 mmol/l were 98.2% specific in predicting the need for hospital admission, 96% specific in predicting mortality in hospitalized nonhypotensive patients, and 87.5% specific in predicting mortality in hypotensive patients. We found that 10% of patients in the EGDT study  presented with a mean arterial pressure above 65 mmHg and lactate levels above 4 mmol/l, and had an even greater mortality than did the hypotensive cohorts when randomized to the control group. More recently, Shapiro and coworkers  and many others [5, 8] confirmed the association of elevated lactate (greater than 4 mmol/l) with increased mortality, ranging between 36% and 39%, in patients with suspected infection.
In their study, the findings of which are reported in the previous issue of Critical Care, Ho and coworkers  did not employ any control or protocol group for interventions as a comparator for the EGDT patients. The authors mention timely administration of antibiotics, central venous pressures of 10.8 ± 4.7 mmHg, and use of vasopressor agents in 70% of the patients as an indicator of aggressive intervention in the ED. Although this comparison is respected, these retrospective data transmit other signals. The early use of vasopressors is not necessarily a sign of an aggressive level of care; it may be a sign of inadequate volume resuscitation and of resorting to vasopressors to support blood pressure. In a hypovolemic patient, increasing afterload with vasopressors will falsely increase central venous pressure, which will limit further attempts at volume resuscitation and further impair microcirculatory flow. This has been associated with deleterious outcomes. A prospective, consensus derived, comprehensive strategy to address all facets of hemodynamic perturbations was used in the EGDT trial . These endpoints have also been externally validated . The evolution of improvements in sepsis mortality during the period examined by Ho and coworkers was not just attributable to EGDT but other interventions as well. Therapies such as recombinant activated protein C, glucose control, and use of corticosteroids were not mentioned. If these sepsis therapies are to be questioned or re-studied, then it should be done with respectful scientific methodology.
Although the data presented by the authors based on their retrospective examination of patients at their institution suggest a lower incidence and mortality (26.9%), this contradicts comparative data from other published studies in the same region. A seminal multicenter trial comparing albumin with crystallinoid fluid therapy conducted in New Zealand and Australia  found a sepsis mortality of 30.7–35.3%. The patients with acute respiratory distress syndrome had an even higher mortality of 39.3–42.4%. This mortality is more comparable to US assessments. Even though the mortality, as stated by the authors, was lower than that in the EGDT trial, it is still high and unacceptable nonetheless. If these patients were trauma, myocardial infarction, or stroke patients, then this mortality would be unacceptable because international initiatives have reduced mortality in all of these diseases. Interestingly, Ho and coworkers  made reference to the work of Shapiro and colleagues , who recently found the same relative mortality reduction after implementation of a standard operating procedure using EGDT. Others have found similar baseline mortality rates and improvements in outcome compared to the EGDT study [13–15].
The EGDT trial  was performed in a very busy inner city ED by board certified emergency physicians who were experts in the early management of sepsis. A recent Institute of Medicine Report (June 2006) confirmed the merits of early hemodynamic optimization. It reports that critical illness is poorly processed in overcrowded EDs in the USA and is responsible for significant mortality. The EGDT trial emphasized that management of the septic patient must begin at the point of diagnosis, which is frequently outside the intensive care unit. Although the models of providing this care may vary from institution to institution, providing this missing link to the chain of care is significantly cost-effective and life saving, which makes it even more generalizable . This call into question the inference that differences in mortality result from the different health care systems. The authors' claim that the processing of critical illness from the ED to hospitalization in Australia is unique contradicts findings reported by Parkhe and coworkers  (Victoria Hospital in Melbourne). That study similarly showed that patients transferred to the intensive care unit within 24 hours of ward admission from the ED had a significant increase in 30-day mortality (relative risk of 2.46) compared with patients admitted to the intensive care unit directly from the ED.
The emerging role of the ED in severe sepsis and septic shock is a much needed and evolving part of the landscape of critical care medicine . Although the merits of EGDT and frequency of eligible patients are minimized by Ho and coworkers and followed by a call for a multicenter trial, the Society of Critical Care Medicine and Surviving Sepsis Campaign has opted not to wait but to adopt the same rational approach of subspecialists such as surgeons, cardio-logists, and neurologists in applying 'right care, right now'.
= emergency repartment
= early goal-directed therapy.
Ho BCH, Bellomo R, McGain F, Jones D, Naka T, Wan L, Brait-berg G: The incidence and outcome of septic shock patients in the absence of early-goal directed therapy. Crit Care 2006, 10: R80. 10.1186/cc4918
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345: 1368-1377. 10.1056/NEJMoa010307
Aduen J, Bernstein WK, Miller J, Kerzner R, Bhatiani A, Davison L, Chernow B: Relationship between blood lactate concentrations and ionized calcium, glucose, and acid-base status in critically ill and noncritically ill patients. Crit Care Med 1995, 23: 246-252. 10.1097/00003246-199502000-00008
Husain FA, Martin MJ, Mullenix PS, Steele SR, Elliott DC: Serum lactate and base deficit as predictors of mortality and morbidity. Am J Surg 2003, 185: 485-491. 10.1016/S0002-9610(03)00044-8
Berkman MR, Shapiro N: Anion gap as a screening tool for elevated lactate in patients with an increased risk of developing sepsis in the emergency department (ED). Acad Emerg Med 2004, 11: 570-b-1. 10.1197/j.aem.2004.02.254
Gunnerson KJ, Saul M, He S, Kellum JA: Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients. Crit Care 2006, 10: R22. 10.1186/cc3987
Shapiro NI, Howell MD, Talmor D, Nathanson LA, Lisbon A, Wolfe RE, Weiss JW: Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 2005, 45: 524-528. 10.1016/j.annemergmed.2004.12.006
Trzeciak S, Chansky ME, Dellinger RP, Hollenberg SM, Parrillo JE: Operationalizing the use of serum lactate measurement for identifying high risk of death in a clinical practice algorithm for suspected severe sepsis. Acad Emerg Med 2006, (Suppl 1):S150-b-1.
Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine: Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 1999, 27: 639-660.
Varpula M, Tallgren M, Saukkonen K, Voipio-Pulkki LM, Pettila V: Hemodynamic variables related to outcome in septic shock. Intensive Care Med 2005, 31: 1066-1071. 10.1007/s00134-005-2688-z
Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350: 2247-2256. 10.1056/NEJMoa040232
Shapiro NI, Howell MD, Talmor D, Lahey D, Ngo L, Buras J, Wolfe RE, Weiss JW, Lisbon A: Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 2006, 34: 1025-1032. 10.1097/01.CCM.0000206104.18647.A8
Kortgen A, Niederprum P, Bauer M: Implementation of an evidence-based 'standard operating procedure' and outcome in septic shock. Crit Care Med 2006, 34: 943-949. 10.1097/01.CCM.0000206112.32673.D4
Trzeciak S, Dellinger RP, Abate NL, Cowan RM, Stauss M, Kilgan-non JH, Zanotti S, Parrillo JE: Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest 2006, 129: 225-232. 10.1378/chest.129.2.225
Sebat F, Johnson D, Musthafa AA, Watnik M, Moore S, Henry K, Saari M: A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients. Chest 2005, 127: 1729-1743. 10.1378/chest.127.5.1729
Huang DT, Dremsizov TT, Rivers EP, Clermont G: Cost-effectiveness of early goal-directed therapy in the treatment of severe sepsis and septic shock. Crit Care 2003, 7: 232. 10.1186/cc2121
Parkhe M, Myles PS, Leach DS, Maclean AV: Outcome of emergency department patients with delayed admission to an intensive care unit. Emerg Med (Fremantle) 2002, 14: 50-57.
Huang DT, Osborn TM, Gunnerson KJ, Gunn SR, Trzeciak S, Kimball E, Fink MP, Angus DC, Dellinger RP, Rivers EP, Society of Critical Care Medicine, American College of Emergency Physicians, Society of Academic Emergency Medicine, Council of Emergency Medicine Residency Directors, Emergency Medicine Residents Association: Critical care medicine training and certification for emergency physicians. Crit Care Med 2005, 33: 2104-2109. 10.1097/01.CCM.0000173412.43562.B3
In the past ER has received consultancy or speaker fees from Edwards Lifesciences, Eli Lilly and Biosite.
About this article
Cite this article
Rivers, E. The outcome of patients presenting to the emergency department with severe sepsis or septic shock. Crit Care 10, 154 (2006). https://doi.org/10.1186/cc4973
- Severe Sepsis
- Lactic Acidosis
- Survive Sepsis Campaign
- Sepsis Mortality
- Hemodynamic Perturbation